We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASFY Divests Hydrosulfite Assets as Portfolio Review Continues
Read MoreHide Full Article
Key Takeaways
Silox to acquire BASF's hydrosulfite-related IP, special containers, equipment and trademarks.
BASF will discontinue hydrosulfite production at Ludwigshafen as part of its strategic portfolio review.
The deal strengthens Silox's position in sodium hydrosulfite reducing and bleaching agents.
BASF SE (BASFY - Free Report) has signed a definitive agreement to divest hydrosulfite-related assets to Silox. The transaction includes intellectual property rights, special containers, selected production equipment, technical expertise and associated trademarks in the company’s hydrosulfite business.
The deal follows BASF’s earlier decision announced in September 2025 to discontinue hydrosulfite production at its Ludwigshafen Site as part of a strategic portfolio review. By divesting these assets, BASF will streamline its portfolio while focusing on other inorganic chemicals produced at the Ludwigshafen plant, including alcoholates, sulfites and nitrogen salts.
The acquisition will strengthen Silox’s position as a leading producer of sodium hydrosulfite-based reducing and bleaching agents. With more than 70 years of expertise and production facilities in Belgium, India and Canada, the company emerges as a trusted partner in the global market. As hydrosulfites play a crucial role in various industrial applications, particularly as reducing agents in textile dyeing and as bleaching additives in pulp and paper production.
Silox Group, through the acquisition, reinforces its long-term commitment to the textile and paper industries. The agreement also reflects BASF’s strategy of prioritizing portfolio optimization.
BASFY stock has slumped 5.2% over the past year compared with the industry’s 8.3% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Agnico Eagle Mines Limited (AEM - Free Report) ,Compañía de Minas Buenaventura S.A.A. (BVN - Free Report) and Balchem Corporation (BCPC - Free Report) .
The Zacks Consensus Estimate for AEM’s 2026 earnings is pegged at $13.28 per share, indicating a rise of 60.39% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 10.77%. AEM’s shares have soared 127.8% over the past year.
The Zacks Consensus Estimate for BVN’s 2026 earnings is pinned at $3.88 per share, indicating a 17.58% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 80.4%. BVN’s shares have jumped 183.9% over the past year.
The Zacks Consensus Estimate for BCPC’s 2026 earnings is pinned at $5.47 per share, indicating a 6.2% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the four trailing quarters, while missing it in the remaining two. BCPC’s shares have gained 2.7% over the past year.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
BASFY Divests Hydrosulfite Assets as Portfolio Review Continues
Key Takeaways
BASF SE (BASFY - Free Report) has signed a definitive agreement to divest hydrosulfite-related assets to Silox. The transaction includes intellectual property rights, special containers, selected production equipment, technical expertise and associated trademarks in the company’s hydrosulfite business.
The deal follows BASF’s earlier decision announced in September 2025 to discontinue hydrosulfite production at its Ludwigshafen Site as part of a strategic portfolio review. By divesting these assets, BASF will streamline its portfolio while focusing on other inorganic chemicals produced at the Ludwigshafen plant, including alcoholates, sulfites and nitrogen salts.
The acquisition will strengthen Silox’s position as a leading producer of sodium hydrosulfite-based reducing and bleaching agents. With more than 70 years of expertise and production facilities in Belgium, India and Canada, the company emerges as a trusted partner in the global market. As hydrosulfites play a crucial role in various industrial applications, particularly as reducing agents in textile dyeing and as bleaching additives in pulp and paper production.
Silox Group, through the acquisition, reinforces its long-term commitment to the textile and paper industries. The agreement also reflects BASF’s strategy of prioritizing portfolio optimization.
BASFY stock has slumped 5.2% over the past year compared with the industry’s 8.3% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Agnico Eagle Mines Limited (AEM - Free Report) ,Compañía de Minas Buenaventura S.A.A. (BVN - Free Report) and Balchem Corporation (BCPC - Free Report) .
While AEM and BVN sport a Zacks Rank #1 (Strong Buy) each at present, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for AEM’s 2026 earnings is pegged at $13.28 per share, indicating a rise of 60.39% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 10.77%. AEM’s shares have soared 127.8% over the past year.
The Zacks Consensus Estimate for BVN’s 2026 earnings is pinned at $3.88 per share, indicating a 17.58% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 80.4%. BVN’s shares have jumped 183.9% over the past year.
The Zacks Consensus Estimate for BCPC’s 2026 earnings is pinned at $5.47 per share, indicating a 6.2% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the four trailing quarters, while missing it in the remaining two. BCPC’s shares have gained 2.7% over the past year.